Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive rosuvastatin for subclinical coronary atherosclerosis assessed by IVUS
ChiCTR-ONC-14004265Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rosuvastatin in acute coronary syndrome (ACS) and coronary arteriosclerosis, sponsored by Beijing Friendship Hospital. Primary endpoints: Total plaque volume and Percent atheroma volume. Started Feb 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-ONC-14004265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-14004265.